Abstract: Described herein are methods and compositions for using microbial agents (probiotics) and agents that promote growth of certain microbes (prebiotics) for management (including prevention and treatment) of musculoskeletal disorders, including osteoporosis, osteopenia, Paget's disease, stunting, osteoarthritis, osteomyelitis, and delayed or non-union fractures.
Type:
Grant
Filed:
July 29, 2022
Date of Patent:
July 30, 2024
Assignee:
Solarea Bio, Inc.
Inventors:
Gerardo V. Toledo, Maria Juliana Soto-Giron, Jinwoo Kim, Julie E. Button, Eric Michael Schott
Abstract: This disclosure provides for compositions (e.g., pharmaceutical compositions, dietary supplements, medical foods and food stuff), comprising combinations of live microbe populations for the treatment and/or prevention of immune system disorders and conditions related to inflammation, including both pathogen assisted conditions and conditions that are independent of pathogens. Included with the present disclosure are methods for use of the compositions, and methods for selecting microbial entities to formulate the compositions of the disclosure.
Type:
Grant
Filed:
April 20, 2023
Date of Patent:
June 25, 2024
Assignee:
SOLAREA BIO, INC.
Inventors:
Eric Michael Schott, Gerardo V. Toledo, Maria Juliana Soto-Giron, Alicia Eve Ballok, Ryan Green, Mark Charbonneau
Abstract: Described herein are methods and compositions for using microbial agents (probiotics) and agents that promote growth of certain microbes (prebiotics) for management (including prevention and treatment) of musculoskeletal disorders, including osteoporosis, osteopenia, Paget's disease, stunting, osteoarthritis, osteomyelitis, and delayed or non-union fractures. Also described herein are methods and compositions for using probiotics and prebiotics for management of inflammation, and symptoms of menopause.
Type:
Grant
Filed:
November 7, 2022
Date of Patent:
May 14, 2024
Assignee:
SOLAREA BIO, INC.
Inventors:
Eric Michael Schott, Gerardo V. Toledo, Maria Juliana Soto-Giron
Abstract: Described herein are methods and compositions for using microbial agents (probiotics) and agents that promote growth of certain microbes (prebiotics) for management (including prevention and treatment) of musculoskeletal disorders, including osteoporosis, osteopenia, Paget's disease, stunting, osteoarthritis, osteomyelitis, and delayed or non-union fractures. Also described herein are methods and compositions for using probiotics and prebiotics for management of inflammation, and symptoms of menopause.
Type:
Grant
Filed:
March 9, 2023
Date of Patent:
March 26, 2024
Assignee:
Solarea Bio, Inc.
Inventors:
Eric Michael Schott, Maria Juliana Soto-Giron, Gerardo V. Toledo
Abstract: Described herein are methods and compositions for using microbial agents (probiotics) and agents that promote growth of certain microbes (prebiotics) for management (including prevention and treatment) of musculoskeletal disorders, including osteoporosis, osteopenia, Paget's disease, stunting, osteoarthritis, osteomyelitis, and delayed or non-union fractures.
Type:
Grant
Filed:
November 25, 2019
Date of Patent:
November 21, 2023
Assignee:
Solarea Bio, Inc.
Inventors:
Gerardo V. Toledo, Eric Michael Schott, Maria Juliana Soto-Giron, Jinwoo Kim, Julie E. Button
Abstract: The present invention relates to the identification of a group of microorganisms, which are relatively abundant in the microbial communities associated with fruits and vegetables typically consumed raw and therefore transient or permanent members of the human microbiota. The consumption of mixtures of these microbes at relevant doses will produce a beneficial effect in the host by reducing the propensity to diabetes, obesity and metabolic syndrome mediated in part by production of short chain fatty acids to enhance colonic butyrate production. Therapeutic methods of the invention involve the use of live microorganisms or metabolites derived from said microorganisms to establish a microbial composition in the mammalian host that will improve significantly the ability to control weight, reduce the onset of diabetes, obesity and metabolic syndrome, and improve overall health.
Type:
Grant
Filed:
March 20, 2020
Date of Patent:
October 24, 2023
Assignee:
SOLAREA BIO, INC.
Inventors:
Gerardo V. Toledo, Tracy Mincer, Jahir Mauricio Gutierrez Bugarin, Jillian DeWalt, Eric Schott, Maria Juliana Soto Giron
Abstract: The present invention relates to the identification of a group of microorganisms, which are relatively abundant in the microbial communities associated with fruits and vegetables typically consumed raw and therefore transient or permanent members of the human microbiota. The consumption of mixtures of these microbes at relevant doses will produce a beneficial effect in the host by reducing the propensity to diabetes, obesity and metabolic syndrome mediated in part by production of short chain fatty acids to enhance colonic butyrate production. Therapeutic methods of the invention involve the use of live microorganisms or metabolites derived from said microorganisms to establish a microbial composition in the mammalian host that will improve significantly the ability to control weight, reduce the onset of diabetes, obesity and metabolic syndrome, and improve overall health.
Type:
Grant
Filed:
December 28, 2018
Date of Patent:
March 24, 2020
Assignee:
Solarea Bio, Inc.
Inventors:
Gerardo V. Toledo, Tracy Mincer, Jahir Mauricio Gutierrez Bugarin, Jillian DeWalt, Eric Schott, Maria Juliana Soto Giron